Narcanti | Australian Register of Therapeutic Goods | Australia | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Narcanti
Australia

PharmaCompass Sponsored Ads

Contact Supplier

Naloxone Hydrochloride

Contact Supplier

pharmacompass-1-m-2026-01-12

PharmaCompass Sponsored Ads

Contact Supplier

Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

Contact Supplier

pharmacompass-2-m-2025-11-03

Narcanti

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 13 USDMF, 11 CEP/COS, 1 JDMF, 3 EU WC, 3 KDMF, 18 NDC API, 17 Listed Suppliers, $ API Reference Price

39 API Suppliers
13 USDMF
11 CEP/COS
1 JDMF
3 EU WC
3 KDMF
18 NDC API
17 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

93 Drugs in Development

93 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

562 FDF Dossiers, 169 FDA Orange Book, 280 Europe, 19 Canada, 52 Australia, 11 South Africa, 31 Listed Dossiers

562 FDF Dossiers
169 FDA Orange Book
280 Europe
19 Canada
52 Australia
11 South Africa
31 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FILM;BUCCAL - EQ 2.1MG BASE;EQ 0.3MG BASE, FILM;BUCCAL - EQ 4.2MG BASE;EQ 0.7MG BASE, FILM;BUCCAL - EQ 6.3MG BASE;EQ 1MG BASE, SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.4MG/0.4ML (0.4MG/0.4ML), TABLET;SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 2MG/0.4ML (2MG/0.4ML), FILM;BUCCAL, SUBLINGUAL - EQ 12MG BASE;EQ 3MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 4MG BASE;EQ 1MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE

FILM;BUCCAL - EQ 2.1MG BASE;EQ 0.3MG BASE
FILM;BUCCAL - EQ 4.2MG BASE;EQ 0.7MG BASE
FILM;BUCCAL - EQ 6.3MG BASE;EQ 1MG BASE
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.4MG/0.4ML (0.4MG/0.4ML)
TABLET;SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 2MG/0.4ML (2MG/0.4ML)
FILM;BUCCAL, SUBLINGUAL - EQ 12MG BASE;EQ 3MG BASE
FILM;BUCCAL, SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE
FILM;BUCCAL, SUBLINGUAL - EQ 4MG BASE;EQ 1MG BASE
FILM;BUCCAL, SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem, 4 Rochem International Inc, 18 SPI Pharma, 3 DKSH, 1 Pharm-RX Chemical, 3 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 4 Kirsch Pharma, 1 Panvo Organics, 1 ACG Worldwide, 10 Actylis, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 16 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 10 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 2 Finar, 7 Gangwal Chemicals, 4 Ideal Cures, 4 Ingredion Pharma Solutions, 24 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 23 Roquette, 7 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 1 Symrise, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

65 Fillers, Diluents & Binders, 40 Coating Systems & Additives, 37 Direct Compression, 28 Granulation, 27 Taste Masking, 26 Thickeners and Stabilizers, 22 Disintegrants & Superdisintegrants, 20 Chewable & Orodispersible Aids, 19 Controlled & Modified Release, 19 Lubricants & Glidants, 14 Co-Processed Excipients, 13 Parenteral, 10 Topical, 9 Solubilizers, 6 Film Formers & Plasticizers, 5 Empty Capsules, 5 API Stability Enhancers, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 Emulsifying Agents, 2 Coloring Agents, 1 Surfactant & Foaming Agents

65 Fillers, Diluents & Binders
40 Coating Systems & Additives
37 Direct Compression
28 Granulation
27 Taste Masking
26 Thickeners and Stabilizers
22 Disintegrants & Superdisintegrants
20 Chewable & Orodispersible Aids
19 Controlled & Modified Release
19 Lubricants & Glidants
14 Co-Processed Excipients
13 Parenteral
10 Topical
9 Solubilizers
6 Film Formers & Plasticizers
5 Empty Capsules
5 API Stability Enhancers
5 Rheology Modifiers
4 Vegetarian Capsules
4 Emulsifying Agents
2 Coloring Agents
1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 261 News #PharmaBuzz

1 Data Compilation #PharmaFlow
261 News #PharmaBuzz

GLOBAL SALES INFORMATION

37 US Medicaid Prescriptions, 40 Regulatory FDF Prices

37 US Medicaid Prescriptions
40 Regulatory FDF Prices

MARKET PLACE

20 APIs, 10 FDF Dossiers

20 APIs
10 FDF Dossiers

PATENTS & EXCLUSIVITIES

149 US Patents, 2 US Exclusivities, 27 Health Canada Patents

149 US Patents
2 US Exclusivities
27 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 7 Others

3 EDQM
7 Others

$ API Ref.Price (USD/KG) : 8,078 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

52 All

01 18Apotex Pty Ltd

02 2Indivior Pty Ltd

03 3Juno Pharmaceuticals Pty Ltd

04 20Mundipharma Pty Limited

05 3Pfizer Australia Pty Ltd

06 3Phebra Pty Ltd

07 3Southern XP Pty Ltd

filter Active Ingredients Reset all filters

52 All

01 2Buprenorphine + naloxone

02 14Naloxone

03 36Oxycodone + naloxone

filter Dosage Form Reset all filters

52 All

01 2Film

02 36Tablet

03 14Blank

filter Brand Name Reset all filters

52 All

01 2ARX-Oxycodone/Naloxone 10/5

02 2ARX-Oxycodone/Naloxone 15/7.5

03 2ARX-Oxycodone/Naloxone 2.5/1.25

04 2ARX-Oxycodone/Naloxone 20/10

05 2ARX-Oxycodone/Naloxone 30/15

06 2ARX-Oxycodone/Naloxone 40/20

07 2ARX-Oxycodone/Naloxone 5/2.5

08 2ARX-Oxycodone/Naloxone 60/30

09 2ARX-Oxycodone/Naloxone 80/40

10 3NALOXONE SXP

11 1NARCAN

12 3Naloxone Hydrochloride (DBL)

13 3Naloxone Juno

14 2Nyxoid

15 2Prenoxad

16 1Suboxone Film 2/0.5

17 1Suboxone Film 8/2

18 2Targin 10/5mg

19 2Targin 15/7.5mg

20 2Targin 2.5/1.25 mg

21 2Targin 20/10mg

22 2Targin 30/15 mg

23 2Targin 40/20mg

24 2Targin 5/2.5mg

25 2Targin 60/30

26 2Targin 80/40

Veranova Naloxone hydrochloride

List of Suppliers

Product Main Page

01

Apotex Pty Ltd

VMX

Not Confirmed

Apotex Pty Ltd

VMX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Oxycodone + naloxone

Brand Name : ARX-Oxycodone/Naloxone 15/7.5

Dosage Form : Tablet

Dosage Strength : 15MG

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Apotex Pty Ltd

VMX

Not Confirmed

Apotex Pty Ltd

VMX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Oxycodone + naloxone

Brand Name : ARX-Oxycodone/Naloxone 30/15

Dosage Form : Tablet

Dosage Strength : 30MG

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Apotex Pty Ltd

VMX

Not Confirmed

Apotex Pty Ltd

VMX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Oxycodone + naloxone

Brand Name : ARX-Oxycodone/Naloxone 2.5/1.25

Dosage Form : Tablet

Dosage Strength : 2.5MG

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Juno Pharmaceuticals Pty Ltd

VMX

Not Confirmed

Juno Pharmaceuticals Pty Ltd

VMX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Brand Name : Naloxone Juno

Dosage Form :

Dosage Strength :

Packaging : 5

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Juno Pharmaceuticals Pty Ltd

VMX

Not Confirmed

Juno Pharmaceuticals Pty Ltd

VMX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Brand Name : Naloxone Juno

Dosage Form :

Dosage Strength :

Packaging : 5

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Mundipharma Pty Limited

VMX

Not Confirmed

Mundipharma Pty Limited

VMX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Oxycodone + naloxone

Brand Name : Targin 15/7.5mg

Dosage Form : Tablet

Dosage Strength : 15MG

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Mundipharma Pty Limited

VMX

Not Confirmed

Mundipharma Pty Limited

VMX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Oxycodone + naloxone

Brand Name : Targin 30/15 mg

Dosage Form : Tablet

Dosage Strength : 30MG

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Mundipharma Pty Limited

VMX

Not Confirmed

Mundipharma Pty Limited

VMX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Oxycodone + naloxone

Brand Name : Targin 2.5/1.25 mg

Dosage Form : Tablet

Dosage Strength : 2.5MG

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Pfizer Australia Pty Ltd

VMX

Not Confirmed

Pfizer Australia Pty Ltd

VMX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Brand Name : Naloxone Hydrochloride (DBL)

Dosage Form :

Dosage Strength :

Packaging : 5

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Southern XP Pty Ltd

Country

VMX

Not Confirmed

Southern XP Pty Ltd

Country

VMX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info :

Registration Country : Australia

Brand Name : NALOXONE SXP

Dosage Form :

Dosage Strength :

Packaging : 5

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.